Founded 2021
Industry
Resiliency + Adaptation
Nicole Black, PhD
Vice President of Biomaterials and Innovation
Mischa Jurkiewicz, MBA
Senior Manager of Global Strategic Marketing
Nicholas Traugutt, PhD
Senior Scientist
Moritz Mond, MS
Mechanical Engineer
Sophia Smith, MEng
Material Engineer
Patrick Holmes, ALAT, LAT
Research Technician
Articles
- Harvard’s eardrum-restoring PhonoGraft enters commercial development
- FDA APPROVAL SOUGHT FOR 3D PRINTED PHONOGRAFT THAT HELPS EARDRUM HEAL ITSELF
- Healing Ruptured Eardrums With A New 3-D Printed Graft
- How a 3D-printed graft could speed healing of ruptured eardrums
- 3D-Printing Resin for Dental Prosthetics Market 2029
- Desktop Health™ Announces Flexcera™ Base Ultra+ Dental Resin for Stronger, More Comfortable 3D Printed Dentures
- Carbon Teams Up with Dental Technology Leaders for Enhanced Patient Outcomes
- Desktop Health Launches ScanUp™ Digital Dentistry Adoption Subscription Program to Modernize Dental Practice Efficiency and Patient Care
About the Company
Desktop Health develops, manufactures, and markets a suite of leading 3D printing and biofabrication solutions. Specifically, their team at Greentown Labs is creating novel regenerative and biomimetic tissue grafts using biodegradable materials and additive manufacturing technologies.
About the Solution
Desktop Health is developing PhonoGraft, a novel device for the repair of chronic eardrum perforations. Eardrum perforations occur from reasons including ear infections, traumatic injuries, and blast injuries. Currently available patient-derived and animal-derived tissue grafts lead to poor hearing and healing outcomes in patients. PhonoGraft comprises a biomimetic architecture that matches the circular and radial structure of the normal eardrum and a novel biodegradable material that remodels into tissue in the structure of the print path. PhonoGraft uses a novel biodegradable, synthetic material to reconstruct the eardrum in a biomimetic manner. PhonoGraft has shown improved outcomes in animal models compared to current standard of care graft materials.